InterpretOmics

InterpretOmics operates as a niche bioinformatics firm focused on next-generation sequencing (NGS) data analysis, particularly in genomics and oncology applications.

Reviewed by 7wData
Share Email

On this page

Profile

Analyzes genomic data to identify disease biomarkers and agricultural traits using next-generation sequencing.

InterpretOmics operates as a niche bioinformatics firm focused on next-generation sequencing (NGS) data analysis, particularly in genomics and oncology applications. The company appears to have roots in academic research, evidenced by its detailed technical blog posts on organelle DNA variability, phage display peptide selection, and precision oncology workflows. Its content emphasizes Illumina platform compatibility and Cytoscape-based visualization tools, suggesting deep integration with these industry-standard technologies.

While no founding date or leadership team is disclosed publicly, the site's publications indicate active involvement in molecular biology research collaborations, particularly in plant genomics and cancer biomarker discovery. Financials and headcount remain undisclosed, but the technical depth of its published work implies a small team of bioinformatics specialists. Recent posts (2021-2022) highlight applications in metastatic breast cancer profiling and arsenic-binding motif identification, positioning the company at the intersection of agricultural genomics and clinical diagnostics. The lack of recent updates (nothing after early 2022) raises questions about current operational status.

Track InterpretOmics and 240+ vendors.

48k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Academic genomics research labs
  • Oncology diagnostics developers
  • Agricultural biotechnology firms
  • Pharmaceutical R&D teams
  • Government-funded molecular biology programs

Strengths and what to watch

Strengths

  • Demonstrated expertise in Illumina platform data analysis pipelines
  • Published methodology for organelle DNA variant detection in barley crops
  • Multidisciplinary approach combining NGS with phage display techniques

Watch for

  • No visible updates or publications since early 2022 suggests possible inactivity
  • Heavy reliance on academic collaborations without clear commercial traction
  • Niche focus on barley and breast cancer may limit market scalability

Key Information

Founded
2009
Headquarters
Bengaluru

Frequently Asked Questions

What does InterpretOmics do?

InterpretOmics specializes in analyzing genomic data using next-generation sequencing to identify disease biomarkers and agricultural traits. The company focuses on genomics and oncology applications, integrating Illumina platforms and Cytoscape-based visualization tools for advanced bioinformatics solutions.

How does InterpretOmics use next-generation sequencing?

InterpretOmics leverages next-generation sequencing (NGS) to analyze genomic data for applications like cancer biomarker discovery and agricultural genomics. Their workflows include Illumina platform compatibility and Cytoscape-based visualization, enabling precise insights into organelle DNA variability and phage display peptide selection.

What industries does InterpretOmics serve?

InterpretOmics serves academic genomics labs, oncology diagnostics developers, agricultural biotech firms, pharmaceutical R&D teams, and government-funded molecular biology programs. Their expertise spans plant genomics, cancer research, and microbial genomics, catering to diverse scientific and industrial needs.

What are InterpretOmics' strengths in genomic analysis?

InterpretOmics excels in Illumina platform data analysis pipelines, organelle DNA variant detection in barley crops, and multidisciplinary approaches combining NGS with phage display techniques. Their published methodologies demonstrate technical depth in genomics and oncology applications.

What are InterpretOmics' applications in agriculture?

InterpretOmics applies genomic analysis to agricultural traits, focusing on organelle DNA variability in crops like barley. Their research supports advancements in plant genomics, enabling the identification of traits for improved crop resilience and productivity.

What oncology applications does InterpretOmics focus on?

InterpretOmics focuses on oncology applications such as metastatic breast cancer profiling and precision oncology workflows. Their next-generation sequencing techniques help identify cancer biomarkers, supporting clinical diagnostics and therapeutic development in oncology research.

Sources

  1. interpretomics.co — Expertise in plant organelle DNA analysis using Illumina sequencing
  2. interpretomics.co — Oncology applications of NGS in clinical settings
  3. interpretomics.co — Technical capabilities in molecular cloning and protein expression
  4. interpretomics.co — Microbial genomics research focus